RADIATION THERAPY ONCOLOGY GROUP
RTOG 0848
A PHASE III TRIAL EVALUATING BOTH ERLOTINIB AND CHEMORADIATION AS ADJUVANT TREATMENT FOR PATIENTS WITH RESECTED HEAD OF PANCREAS ADENOCARCINOMA
RTOG 0848
A PHASE III TRIAL EVALUATING BOTH ERLOTINIB AND CHEMORADIATION AS ADJUVANT TREATMENT FOR PATIENTS WITH RESECTED HEAD OF PANCREAS ADENOCARCINOMA
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I is required for this protocol.
- Download fillable form and complete it.
- Submit to RTOG RT Quality Assurance Department
Email: rtog-facquest@phila.acr.org Fax: 215-940-8817
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Check list
- ATC Compliant Treatment Planning Systems
- Structure Names
- Pancreas Atlas
- Protocol Text (http://www.rtog.org/)
Back to protocols
